Literature DB >> 11755344

The discovery of small molecule carbamates as potent dual alpha(4)beta(1)/alpha(4)beta(7) integrin antagonists.

Linda L Chang1, Quang Truong, Richard A Mumford, Linda A Egger, Usha Kidambi, Kathryn Lyons, Ermengilda McCauley, Gail Van Riper, Stella Vincent, John A Schmidt, Malcolm MacCoss, William K Hagmann.   

Abstract

The alpha(4)beta(1) and alpha(4)beta(7) integrins are implicated in several inflammatory disease states. Systematic SAR studies of an alpha(4)beta(1)-specific arylsulfonyl-Pro-Tyr lead led to the identification of a new alpha(4)beta(7) binding site, best captured by O-carbamates of Tyr for this structural class. Several compounds showed a 200- to 400-fold improvement in alpha(4)beta(7) binding affinity while maintaining subnanomolar alpha(4)beta(1) activity, for example 2l, VCAM-Ig alpha(4)beta(1) IC(50)=0.13 nM, VCAM-Ig alpha(4)beta(7) IC(50)=1.92 nM.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11755344     DOI: 10.1016/s0960-894x(01)00710-7

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Small-molecule inhibitors of integrin alpha2beta1 that prevent pathological thrombus formation via an allosteric mechanism.

Authors:  Meredith W Miller; Sandeep Basra; Daniel W Kulp; Paul C Billings; Sungwook Choi; Mary Pat Beavers; Owen J T McCarty; Zhiying Zou; Mark L Kahn; Joel S Bennett; William F DeGrado
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-13       Impact factor: 11.205

2.  Small molecule inhibitors of integrin alpha2beta1.

Authors:  Sungwook Choi; Gaston Vilaire; Cezary Marcinkiewicz; Jeffrey D Winkler; Joel S Bennett; William F DeGrado
Journal:  J Med Chem       Date:  2007-10-04       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.